Methods of producing humanized non-human mammals

A mammalian, non-human technology, applied in the field of manufacturing humanized non-human mammals, which can solve the problems of poor, undetectable and non-functional NK cells and myeloid cells

Inactive Publication Date: 2012-10-10
MASSACHUSETTS INST OF TECH
View PDF2 Cites 24 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

B cell reconstitution is robust and T cell reconstitution is adequate, but both B and T cells are nonfunctional
Furthermore, reconstitution of NK cells and myeloid cells is often poor or undetectable

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of producing humanized non-human mammals
  • Methods of producing humanized non-human mammals
  • Methods of producing humanized non-human mammals

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0104] Expression of human cytokines in humanized mice (Humice) significantly enhanced reconstitution of specific human blood cell lineages.

[0105] Materials and Methods

[0106] HSC isolation, construction of humanized mice, and hydrodynamic gene delivery. Human cord blood was obtained from the Singapore Cord Blood Bank. Cord blood mononuclear cells (MNC) were separated by a Ficoll-diatrizoate density gradient. RosetteSep was used according to the manufacturer's scientific protocol (Stem Cell Technologies) system to purify CD34+ cells. CD34 + The purity of the cells was >95%. To expand HSCs, purified CD34 + Cells were cultured for 11 to 14 days (Zhang CC, Kaba M, Iizuka S, Huynh H, Lodish HF (2008) Blood 111:3415-3423). Humanized mice were generated using unexpanded and expanded HSCs.

[0107] NSG mice were purchased from Jackson Laboratories and maintained under specific pathogen-free conditions in the animal laboratories of Nanyang Technological University and Na...

example 2

[0131] Expression of human cytokines enhances human T and B cell reconstitution and function in humanized mice

[0132] Reconstitution of human T and B cells was adequate in humanized mice, but they did not display optimal function. For example, although human CD8 has been detected after viral challenge + T cell responses, these CD4 + T cell function is abnormal; human B cell-mediated antibody responses are absent in humanized mice. As shown here, abnormalities in human T-cell and B-cell responses are also due to poor cross-reactivity of mouse cytokines with human cells in mice. Shown here is that injection of plasmids encoding human GM-CSF and IL-4 into humice results in human CD209 + Reconstitution of dendritic cells, which are considered the primary antigen-presenting cells against T cells, is enhanced. In addition, IL-4 has also been shown to promote cell proliferation, survival, and immunoglobulin class switching to IgG and IgE in human B cells, and acquisition of a T...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
purityaaaaaaaaaa
Login to view more

Abstract

Provided herein are methods of reconstituting functional human blood cell lineages in a non-human mammal comprising introducing human hematopoietic stem cells (HSCs) and nucleic acid encoding one or more human cytokines into an immunodeficient non-human mammal. The non-human mammal is maintained under conditions in which the nucleic acid is expressed and the human HSCs differentiate into functional human blood cell lineages in the non-human mammal, thereby reconstituting functional human blood cell lineages in the non-human mammal. Also provided are methods of producing human antibodies directed against an immunogen in a non-human mammal, hybridomas that secrete the monoclonal antibodies as well as antibodies (e.g., polyclonal antibodies; monoclonal antibodies) produced by the B cells and non-human mammals produced by the methods.

Description

[0001] related application [0002] This application claims the benefit of US Provisional Application No. 61 / 221,438, filed June 29, 2009. The entire teachings of one or more of the above applications are hereby incorporated by reference. Background of the invention [0003] There is a great need to study the human immune response to pathogen infection in a synthetic and controlled manner in small animal models. Significant efforts have been invested in the past two decades to reconstitute severe combined immunodeficiency (scid) mice lacking T and B lymphocytes with cells of the human blood lineage (Shultz LD, Ishikawa F, Greiner DL (2007) Nat RevImmunol 7:118-130). However, early attempts were unsuccessful due to poor engraftment in recipient mice, rapid disappearance of human T and B cells, or rapid development of hematopoietic malignancies. Achieved by using recipient mice lacking not only T and B cells (due to scid mutations or recombination-activating gene (Rag) mutati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12N5/071
CPCA01K67/0271A01K2267/0381C07K16/2893A01K2227/105A01K2267/0331A61K39/3955A01K2207/12A61K2039/505A01K67/027C07K2317/24A61K2300/00
Inventor 陈清风陈建竹
Owner MASSACHUSETTS INST OF TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap